XRX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. Despite today’s bounce to ~$2.18, the broader trend remains bearish (SMA200>SMA20>SMA5) and price is still below the key pivot (2.353). With no Intellectia buy signals, bearish options positioning (heavy put OI), and a weak earnings print (miss + adjusted loss) alongside negative analyst target cuts, the risk/reward is unfavorable for an impatient buyer looking for immediate upside. Prefer to avoid/exit rather than initiate a new position here.
Trend is bearish: moving averages are stacked negatively (SMA_200 > SMA_20 > SMA_5), indicating a sustained downtrend despite the one-day +7.35% pop. MACD histogram is negative (-0.028) and only “negatively contracting,” suggesting bearish momentum is easing but not reversed. RSI(6)=43.2 is neutral-to-weak, not showing an oversold rebound signal. Key levels: near-term support S1=2.086 (then S2=1.921); resistance/pivot at 2.353, then R1=2.621. With price ~2.18 below the pivot, the setup still favors sellers until reclaiming 2.353 decisively. Pattern-based outlook provided also leans slightly negative (next week ~-2.53%, next month ~-2.84%).
Intellectia Proprietary Trading Signals:
Q4 2025 revenue rose sharply to about $2.03B (~+26% YoY), which can attract short-term bargain hunters at a very low share price. The earnings event has already hit, reducing immediate headline uncertainty.
Earnings quality was weak: revenue increased but missed expectations and the company posted an adjusted loss (-$0.10 EPS) with commentary around integration challenges and market volatility. Technical structure remains bearish and price is below the pivot (2.353). Options positioning shows heavy put demand (bearish sentiment/hedging). Analyst action is negative (price target cuts). No notable supportive flow from insiders/hedge funds (both described as neutral). No recent congress trading data to suggest influential accumulation.
Latest quarter: 2025/Q4. Revenue increased to ~$2.028B (+25.73% YoY), but profitability deteriorated in quality: net income remained negative (-$76M) and EPS was -$0.59. Gross margin fell to 26.92% (-5.41% YoY), signaling margin pressure even as revenue rose—consistent with integration/macro headwinds and not the type of growth that typically sustains a durable uptrend.
Recent trend is negative-to-neutral. Citi kept a Neutral rating but cut its price target twice: to $3.50 (from $4.50) on 2025-11-09 after a miss/lower guide, and again to $2.50 (from $3.50) on 2026-01-30. Wall Street “pros” view (from provided data): Pros—still Neutral (not outright bearish) and target remains above current price. Cons—repeated target cuts reflect worsening confidence and earnings/macro challenges; not a strong buy consensus signal.
